{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:40:21Z","timestamp":1775040021980,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005196","name":"Bureau of Justice Assistance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.drugalcdep.2020.108405","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T17:32:20Z","timestamp":1605202340000},"page":"108405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Changes in opioid prescribing after implementation of mandatory registration and proactive reports within California\u2019s prescription drug monitoring program"],"prefix":"10.1016","volume":"218","author":[{"given":"Alvaro","family":"Castillo-Carniglia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s","family":"Gonz\u00e1lez-Santa Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Cerd\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Delcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron B.","family":"Shev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garen J.","family":"Wintemute","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen G.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2020.108405_bib0005","article-title":"May 17. A penalized synthetic control estimator for disaggregated data","author":"Abadie","year":"2019","journal-title":"Conference on Synthetic Controls and Related Methods. MIT, Cambridge, MA. MIT Institute for Data, Systems, and Society"},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0010","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/ajps.12116","article-title":"Comparative politics and the synthetic control method","volume":"59","author":"Abadie","year":"2014","journal-title":"Am. J. Pol. Sci."},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0015","series-title":"Handbook of Labor Economics","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S1573-4463(99)03004-7","article-title":"Empirical strategies in labor economics","author":"Angrist","year":"1999"},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0020","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/MLR.0000000000000505","article-title":"A detailed exploration into the association of prescribed opioid dosage and overdose deaths among patients with chronic pain","volume":"54","author":"Bohnert","year":"2016","journal-title":"Med. Care"},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0025","doi-asserted-by":"crossref","first-page":"367","DOI":"10.7326\/M18-1243","article-title":"Opioid prescribing in the United States before and after the Centers for Disease Control and Prevention\u2019s 2016 opioid guideline","volume":"169","author":"Bohnert","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0030","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/jech-2017-210106","article-title":"Synthetic control methodology as a tool for evaluating population-level health interventions","volume":"72","author":"Bouttell","year":"2018","journal-title":"J. Epidemiol. Commun. Health"},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0035","series-title":"2018 National Survey on Drug Use and Health","author":"Center for Behavioral Health Statistics and Quality","year":"2019"},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0040","series-title":"Ten Leading Causes of Death and Injury. 2017","author":"Centers for Disease Control and Prevention","year":"2018"},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0045","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/add.13543","article-title":"Prescription opioid poisoning across urban and rural areas: identifying vulnerable groups and geographic areas","volume":"112","author":"Cerda","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0050","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jpain.2017.10.001","article-title":"Association of prescription drug monitoring program use with opioid prescribing and health outcomes: a comparison of program users and nonusers","volume":"19","author":"Deyo","year":"2018","journal-title":"J. Pain"},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0055","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014united States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0060","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1162\/003465398557825","article-title":"Consistent covariance matrix estimation with spatially dependent panel data","volume":"80","author":"Driscoll","year":"1998","journal-title":"Rev. Econ. Stat."},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0065","doi-asserted-by":"crossref","first-page":"783","DOI":"10.7326\/M17-3074","article-title":"Association between prescription drug monitoring programs and nonfatal and fatal drug overdoses","volume":"168","author":"Fink","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0070","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/jamainternmed.2018.6721","article-title":"Assessment of Racial\/Ethnic and income disparities in the prescription of opioids and other controlled medications in California","volume":"179","author":"Friedman","year":"2019","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0075","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1162\/REST_a_00537","article-title":"Regional policy evaluation: interactive fixed effects and synthetic controls","volume":"98","author":"Gobillon","year":"2016","journal-title":"Rev. Econ. Stat."},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0080","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.0217","article-title":"The burden of opioid-related mortality in the United States","volume":"1","author":"Gomes","year":"2018","journal-title":"JAMA Netw Open."},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0085","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/pam.22098","article-title":"Mandatory access prescription drug monitoring programs and prescription drug abuse","volume":"38","author":"Grecu","year":"2018","journal-title":"J. Policy Anal. Manag."},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0090","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1377\/hlthaff.2017.1321","article-title":"Four states with robust prescription drug monitoring programs reduced opioid dosages","volume":"37","author":"Haffajee","year":"2018","journal-title":"Health Aff."},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0095","first-page":"1","article-title":"Drug overdose deaths in the United States, 1999-2017","volume":"329","author":"Hedegaard","year":"2018","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0100","series-title":"Survey of California physicians\u2019 and Pharmacists\u2019 Experience with and Attitudes About CURES 2.0","author":"Henry","year":"2017"},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0105","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/1536867X0700700301","article-title":"Robust standard errors for panel regressions with cross-sectional dependence","volume":"7","author":"Hoechle","year":"2007","journal-title":"Stata J."},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0110","series-title":"Research Report Series Statistics #2012-04","article-title":"An empirical study on using previous American Community survey data versus census 2000 data in SAIPE models for poverty estimates","author":"Huang","year":"2012"},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0115","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.2105\/AJPH.2014.301966","article-title":"Determinants of increased opioid-related mortality in the United States and Canada, 1990-2013: a systematic review","volume":"104","author":"King","year":"2014","journal-title":"Am. J. Public Health"},{"issue":"Suppl 1","key":"10.1016\/j.drugalcdep.2020.108405_bib0120","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.drugalcdep.2016.11.020","article-title":"Validation of prescriber risk indicators obtained from prescription drug monitoring program data","volume":"173","author":"Kreiner","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0125","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/pm\/pny095","article-title":"An experimental test of the effectiveness of unsolicited reporting by a prescription drug monitoring program in reducing inappropriate acquisition of opioids","volume":"20","author":"McDonald","year":"2018","journal-title":"Pain Med."},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0130","first-page":"291","volume":"73","author":"McNamee","year":"2019"},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0135","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/add.13741","article-title":"Do more robust prescription drug monitoring programs reduce prescription opioid overdose?","volume":"112","author":"Pardo","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6409a1","article-title":"Controlled substance prescribing patterns - prescription behavior surveillance system, eight states, 2013","volume":"64","author":"Paulozzi","year":"2015","journal-title":"Surveill. Summ."},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0145","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.drugalcdep.2017.12.002","article-title":"Features of prescription drug monitoring programs associated with reduced rates of prescription opioid-related poisonings","volume":"184","author":"Pauly","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0150","doi-asserted-by":"crossref","DOI":"10.1093\/epirev\/mxaa002","article-title":"Prescription drug monitoring programs and prescription opioid-related outcomes in the United States","author":"Puac-Polanco","year":"2020","journal-title":"Epidemiol. Rev."},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0155","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.amepre.2018.02.009","article-title":"Psychosocial correlates of clinicians\u2019 prescription drug monitoring program utilization","volume":"54","author":"Pugliese","year":"2018","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0160","series-title":"R: a Language and Environment for Statistical Computing","author":"R Core Team","year":"2019"},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0165","series-title":"R Package Version 0.6.0 Ed","article-title":"Censusapi: retrieve data from the census APIs","author":"Recht","year":"2019"},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0170","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jsr.2018.10.011","article-title":"From the CDC: the prevention for states program: preventing opioid overdose through evidence-based intervention and innovation","volume":"68","author":"Robinson","year":"2019","journal-title":"J. Saf. Res."},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0175","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.2105\/AJPH.2018.304704","article-title":"Prescription drug monitoring program: registration and use by prescribers and pharmacists before and after legal mandatory registration, California, 2010\u20132017","volume":"108","author":"Shev","year":"2018","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0180","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/add.14440","article-title":"A typology of prescription drug monitoring programs: a latent transition analysis of the evolution of programs from 1999 to 2016","volume":"114","author":"Smith","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0185","series-title":"Stata Statistical Software: Release 16","author":"StataCorp","year":"2019"},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2019.02.010","article-title":"Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing","volume":"199","author":"Strickler","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0195","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jsat.2018.08.006","article-title":"Variations in prescription drug monitoring program use by prescriber specialty","volume":"94","author":"Sun","year":"2018","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0200","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1377\/hlthaff.2016.1141","article-title":"States with prescription drug monitoring mandates saw a reduction in opioids prescribed to medicaid enrollees","volume":"36","author":"Wen","year":"2017","journal-title":"Health Aff."},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0205","doi-asserted-by":"crossref","first-page":"290","DOI":"10.15585\/mmwr.mm6911a4","article-title":"Drug and opioid-involved overdose deaths \u2014 united States, 2017\u20132018","volume":"69","author":"Wilson","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0210","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev-publhealth-040617-013507","article-title":"Designing difference in difference studies: best practices for public health policy research","volume":"39","author":"Wing","year":"2018","journal-title":"Annu. Rev. Public Health"},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0215","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.drugalcdep.2018.03.036","article-title":"Mandatory review of a prescription drug monitoring program and impact on opioid and benzodiazepine dispensing","volume":"188","author":"Winstanley","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0220","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1017\/pan.2016.2","article-title":"Generalized synthetic control method: causal inference with interactive fixed effects models","volume":"25","author":"Xu","year":"2017","journal-title":"Political Anal."},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0225","series-title":"R Package Version 1.0.9. Ed.","article-title":"Gsynth: generalized synthetic control method","author":"Xu","year":"2019"},{"key":"10.1016\/j.drugalcdep.2020.108405_bib0230","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/pm\/pnx044","article-title":"Unsolicited reporting to prescribers of opioid analgesics by a state prescription drug monitoring program: an observational study with matched comparison group","volume":"19","author":"Young","year":"2017","journal-title":"Pain Med."}],"updated-by":[{"DOI":"10.1016\/j.drugalcdep.2021.108606","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000}}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620305706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620305706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T01:54:29Z","timestamp":1620870869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871620305706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":46,"alternative-id":["S0376871620305706"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108405","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.drugalcdep.2021.108606","asserted-by":"object"}]},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in opioid prescribing after implementation of mandatory registration and proactive reports within California\u2019s prescription drug monitoring program","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108405","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108405"}}